Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradstock, K.
Right arrow Articles by Byth, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradstock, K.
Right arrow Articles by Byth, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts

K Bradstock, V Makrynikola, A Bianchi and K Byth

Haematology Department, Westmead Hospital, New South Wales, Australia.

Normal B lymphopoiesis is dependent on a close relationship between B- cell precursors and the bone marrow (BM) microenvironment. To further understand the mechanisms regulating the proliferation of the malignant counterpart of B-cell precursors, namely precursor-B acute lymphoblastic leukemia (ALL), we examined the adhesion to BM fibroblasts (BMF) of 19 cases of precursor-B ALL using a chromium labeling assay. Eleven of 19 cases showed greater than 10% binding to BMF (range 2.3% to 54.8%, mean 19.1%). Binding was increased approximately twofold by preincubation of BMF with tumor necrosis factor and interleukin-4, which also resulted in upregulation of expression of vascular cell adhesion molecule-1 (VCAM-1) on BMF. The mechanism of attachment was investigated using murine monoclonal antibodies to leukocyte integrins, principally the beta, integrins VLA- 4 and VLA-5, which were demonstrated to be present on most cases by flow cytometry. Statistically significant inhibition of adhesion was observed with antibodies to the beta 1 common subunit, VLA-4, and VLA- 5, whereas little effect was seen with antibodies to VLA-6 or the beta 2 integrin subunit. Preincubation of fibroblasts with an antibody to VCAM-1 (a ligand of VLA-4) inhibited leukemic cell binding in the majority of cases, which was an effect also observed on cytokine- stimulated BMF. However, a minority of cases, as well as the pre-B lines NALM-6 and KM-3, showed no evidence of inhibition of adhesion with anti-VCAM-1 antibodies. Treatment of BMF with antifibronectin antibody alone had little effect on ALL adhesion and did not enhance the inhibitory effect of anti-VCAM-1. These data indicate that precursor-B ALL cells bind to BM stroma through the beta 1 integrins VLA-4 and VLA-5 and that this effect is partly mediated by VCAM-1 on stromal cells, although other undefined VLA ligands are also likely to be involved. Attachment of ALL cells to stroma is likely to play a key role in regulating the survival and growth of these cells through exposure to stromal cytokines.

Volume 82, Issue 11, pp. 3437-3444, 12/01/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. J. Bendall, R. Baraz, J. Juarez, W. Shen, and K. F. Bradstock
Defective p38 Mitogen-Activated Protein Kinase Signaling Impairs Chemotaxic but not Proliferative Responses to Stromal-Derived Factor-1{alpha} in Acute Lymphoblastic Leukemia
Cancer Res., April 15, 2005; 65(8): 3290 - 3298.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. K. Narla, Y. Dong, D. Klis, and F. M. Uckun
Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Antileukemic Agent with Matrix Metalloproteinase Inhibitory Activity
Clin. Cancer Res., April 1, 2001; 7(4): 1094 - 1101.
[Abstract] [Full Text]


Home page
BloodHome page
R. E. Mudry, J. E. Fortney, T. York, B. M. Hall, and L. F. Gibson
Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy
Blood, September 1, 2000; 96(5): 1926 - 1932.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. W. LeBien
Fates of human B-cell precursors
Blood, July 1, 2000; 96(1): 9 - 23.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. B.H. Geijtenbeek, Y. van Kooyk, S. J. van Vliet, M. H. Renes, R. A.P. Raymakers, and C. G. Figdor
High Frequency of Adhesion Defects in B-Lineage Acute Lymphoblastic Leukemia
Blood, July 15, 1999; 94(2): 754 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xiao, Y. Messinger, J. Jin, D. E. Myers, J. B. Bolen, and F. M. Uckun
Signal Transduction through the beta1 Integrin Family Surface Adhesion Molecules VLA-4 and VLA-5 of Human B-cell Precursors Activates CD19 Receptor-associated Protein-tyrosine Kinases
J. Biol. Chem., March 29, 1996; 271(13): 7659 - 7664.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020